Search Within

GME, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (228)
  2. Journal Article (177)
  3. Research Letter (10)
  4. Review (4)
  5. Correspondence (2)
  6. Editorial (2)
Groups
  1. Epidemiology and Biostatistics (423)
  2. Graduate Medical Education (423)
  3. Department of Medicine (399)
  4. Biostatistics Service (340)
  5. Hematology-Oncology Fellows (270)
  6. Hematologic Malignancies, Division of (256)

More Groups

People
  1. Gunjan Shah (95)
  2. Michael Scordo (94)
  3. Andriy Derkach (89)
  4. Sergio Giralt (85)
  5. Kylee Maclachlan (77)
  6. Alexander Lesokhin (71)

More People

Years
  1. 2025 (30)
  2. 2024 (105)
  3. 2023 (136)
  4. 2022 (95)
  5. 2021 (30)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (95)
  2. Blood (74)
  3. Clinical Lymphoma, Myeloma and Leukemia (27)
  4. Clinical Cancer Research (17)
  5. Annals of Oncology (12)
  6. Blood Advances (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. American Society of Hematology (86)
  3. Elsevier Inc. (54)
  4. Nature Publishing Group (38)
  5. American Association for Cancer Research (32)
  6. Oxford University Press (24)

More Publishers

Results (423)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Waiting to exhale: The feasibility and appropriateness of home blood oxygen monitoring in oncology patients post–hospital discharge
    Journal Article

    Liu, S. Y.; Doshi, S. D.; Ebstein, A. M.; Holland, J.; Sapir, A.; Leung, M.; Huang, J.; Fahy, R.; Salvaggio, R.; Begue, A.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of regorafenib in recurrent/metastatic adenoid cystic carcinoma
    Journal Article

    Desilets, A.; Vos, J. L.; Katabi, N.; Kuo, F.; Nadeem, Z.; Linxweiler, M.; Ostrovnaya, I.; Baxi, S.; Dunn, L. A.; Sherman, E. J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of teclistamab among MajesTEC-1 eligible and ineligible population in the real-world setting for the treatment of relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Rajeeve, S.; Hashmi, H.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Single cell whole genome measurement of genomic heterogeneity and clonal evolution in multiple myeloma
    Meeting Abstract

    McPherson, A.; Maclachlan, K.; Myers, M.; Satas, G.; Garcés, J. J.; Lee, H.; Bahlis, N. J.; Usmani, S.; Shah, S.; Maura, F.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save